← Leaderboards
Akiko Iwasaki
Yale University
$25,435,081
Attributed
$32,418,962
Total exposure
19
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,418,962 · 19
By mechanism
R01$27,289,021 · 9
R42$1,833,981 · 1
U54$1,160,769 · 1
R21$913,681 · 2
R56$789,415 · 2
R41$224,997 · 1
Top collaborators
- Shelli Farhadian9 shared
- Leonard K Kaczmarek5 shared
- W Mark Saltzman5 shared
- Pamuk Bilsel3 shared
- Anne Christine Eichmann3 shared
- Jean-Leon Thomas3 shared
- Charles S Dela Cruz1 shared
- Tamas L Horvath1 shared
Most similar at Yale University
Same institution · by research overlap
- Leonard K Kaczmarek$20,168,615
- David Pitt$7,740,406
- Isaac Ssinabulya$1,448,509
- Annsea Park$148,647
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsViralResponseImmuneInfectionImmune ResponseImmunityMediatingDesignLifeDendritic CellsAntiviral AgentsVirusPathogenMolecularMucous MembraneFoundationsVaccinesBaseImmunological InterventionAntigensTransmission ProcessInsightSignal Transduction
Grant awards (85)
Role of meningeal lymphatic vasculature in neuroimmune communication development$494,067
R01 · FY2025 · NS
Role of meningeal lymphatic vasculature in neuroimmune communication development$548,579
R01 · FY2024 · NS
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$417,822
R01 · FY2024 · AI · contact PI
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$1,230,201
R01 · FY2023 · AI · contact PI
Role of viral infections in potassium channel-related cerebellar ataxia$540,244
R01 · FY2023 · NS
Role of meningeal lymphatic vasculature in neuroimmune communication development$524,089
R01 · FY2023 · NS
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$417,822
R01 · FY2023 · AI · contact PI
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$1,235,421
R01 · FY2022 · AI · contact PI
Role of viral infections in potassium channel-related cerebellar ataxia$540,244
R01 · FY2022 · NS
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$417,822
R01 · FY2022 · AI · contact PI
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$70,603
R01 · FY2022 · AI · contact PI
Role of viral infections in potassium channel-related cerebellar ataxia$540,244
R01 · FY2021 · NS
B cell based protection against recurrent herpes$418,750
R01 · FY2021 · AI · contact PI
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$417,822
R01 · FY2021 · AI · contact PI
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$61,789
R01 · FY2021 · AI · contact PI
Role of viral infections in potassium channel-related cerebellar ataxia$540,244
R01 · FY2020 · NS
B cell based protection against recurrent herpes$418,750
R01 · FY2020 · AI · contact PI
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$417,822
R01 · FY2020 · AI · contact PI
Role of viral infections in potassium channel-related cerebellar ataxia$540,244
R01 · FY2019 · NS
B cell based protection against recurrent herpes$418,750
R01 · FY2019 · AI · contact PI
Cellular and molecular transport in mucus$396,106
R01 · FY2019 · EB
Immunity to Genital Herpes Simplex-2$374,625
R01 · FY2019 · AI · contact PI
Restimulating memory T cell responses in elderly by a novel, live influenza vaccine$1,087,654
R42 · FY2018 · AI
B cell based protection against recurrent herpes$418,750
R01 · FY2018 · AI · contact PI
Immunity to Genital Herpes Simplex-2$408,762
R01 · FY2018 · AI · contact PI
Cellular and molecular transport in mucus$396,106
R01 · FY2018 · EB
Innate antiviral defense against Vaginal transmission of ZIKA virus$209,375
R21 · FY2018 · AI · contact PI
Immunity to Genital Herpes Simplex-2$12,422
R01 · FY2018 · AI · contact PI
Restimulating memory T cell responses in elderly by a novel, live influenza vaccine$746,327
R42 · FY2017 · AI
B cell based protection against recurrent herpes$418,750
R01 · FY2017 · AI · contact PI
Immunity to Genital Herpes Simplex-2$374,625
R01 · FY2017 · AI · contact PI
Cellular and molecular transport in mucus$370,822
R01 · FY2017 · EB
Innate antiviral defense against Vaginal transmission of ZIKA virus$251,250
R21 · FY2017 · AI · contact PI
Vaginally-delivered Nanoparticles for Prevention and Treatment of HSV-2 Infections$385,981
R56 · FY2016 · AI
Immunity to Genital Herpes Simplex-2$374,625
R01 · FY2016 · AI · contact PI
Cellular and molecular transport in mucus$1
R01 · FY2016 · EB
Antiviral CTL mobilization to the genital mucosa$415,725
R01 · FY2015 · AI · contact PI
Immunity to Genital Herpes Simplex-2$374,625
R01 · FY2015 · AI · contact PI
Viral Recognition by plasmacytoid dendritic cell$374,134
R01 · FY2015 · AI · contact PI
Restimulating memory T cell responses in elderly by a novel, live influenza vaccine$224,997
R41 · FY2015 · AI
Antiviral CTL mobilization to the genital mucosa$727,771
R01 · FY2014 · AI · contact PI
Autophagy in Antiviral Immunity$409,613
R01 · FY2014 · AI · contact PI
Viral Recognition by plasmacytoid dendritic cell$384,971
R01 · FY2014 · AI · contact PI
Inflammasomes as innate link to antiviral immunity$431,286
U54 · FY2013 · AI · contact PI
Viral Recognition by plasmacytoid dendritic cell$390,785
R01 · FY2013 · AI · contact PI
Antiviral CTL mobilization to the genital mucosa$390,590
R01 · FY2013 · AI · contact PI
Autophagy in Antiviral Immunity$385,036
R01 · FY2013 · AI · contact PI
Immune Induction to Genital Herpes Simplex Virus 2$304,949
R01 · FY2013 · AI · contact PI
Inflammasomes as innate link to antiviral immunity$416,559
U54 · FY2012 · AI · contact PI
Viral Recognition by plasmacytoid dendritic cell$414,479
R01 · FY2012 · AI · contact PI
Antiviral CTL mobilization to the genital mucosa$414,271
R01 · FY2012 · AI · contact PI
Autophagy in Antiviral Immunity$409,613
R01 · FY2012 · AI · contact PI
Immune Induction to Genital Herpes Simplex Virus 2$341,605
R01 · FY2012 · AI · contact PI
Immune Induction to Genital Herpes Simplex Virus 2$418,093
R01 · FY2011 · AI · contact PI
Viral Recognition by plasmacytoid dendritic cell$413,750
R01 · FY2011 · AI · contact PI
Autophagy in Antiviral Immunity$408,731
R01 · FY2011 · AI · contact PI
Inflammasomes as innate link to antiviral immunity$312,924
U54 · FY2011 · AI · contact PI
Antiviral CTL mobilization to the genital mucosa$103,438
R01 · FY2011 · AI · contact PI
Antiviral CTL mobilization to the genital mucosa$403,434
R56 · FY2010 · AI · contact PI
Autophagy in Antiviral Immunity$392,463
R01 · FY2010 · AI · contact PI
Viral recognition by plasmacytoid dendritic cell$385,461
R01 · FY2010 · AI · contact PI
Immune Induction to Genital Herpes Simplex Virus 2$327,690
R01 · FY2010 · AI · contact PI
NLR control of antiviral defense in the respiratory mucosa$204,806
R21 · FY2010 · AI · contact PI
Immune Induction to Genital Herpes Simplex Virus 2$90,146
R01 · FY2010 · AI · contact PI
Viral recognition by plasmacytoid dendritic cell$389,354
R01 · FY2009 · AI · contact PI
Antiviral CTL mobilization to the genital mucosa$380,205
R01 · FY2009 · AI · contact PI
Immune Induction to Genital Herpes Simplex Virus 2$331,000
R01 · FY2009 · AI · contact PI
NLR control of antiviral defense in the respiratory mucosa$248,250
R21 · FY2009 · AI · contact PI
Immune Induction to Genital Herpes Simplex Virus 2$34,188
R01 · FY2009 · AI · contact PI
Viral recognition by plasmacytoid dendritic cell$389,355
R01 · FY2008 · AI · contact PI
Antiviral CTL mobilization to the genital mucosa$380,205
R01 · FY2008 · AI · contact PI
Immune Induction to Genital Herpes Simplex Virus 2$266,144
R01 · FY2008 · AI · contact PI
Viral recognition by plasmacytoid dendritic cell$396,896
R01 · FY2007 · AI · contact PI
Antiviral CTL mobilization to the genital mucosa$387,569
R01 · FY2007 · AI · contact PI
Immune Induction to Genital Herpes Simplex Virus 2$271,299
R01 · FY2007 · AI · contact PI
Generation of Inducible Dermal Dendritic Cell Knockout/Reporter Mice$41,271
P30 · FY2007 · AR · contact PI
Viral recognition by plasmacytoid dendritic cell$408,750
R01 · FY2006 · AI · contact PI
Antiviral CTL mobilization to the genital mucosa$399,144
R01 · FY2006 · AI · contact PI
Immune Induction to Genital Herpes Simplex Virus 2$271,040
R01 · FY2006 · AI · contact PI
Antiviral CTL mobilization to the genital mucosa$347,438
R01 · FY2005 · AI
Immune Induction to Genital Herpes Simplex Virus 2$282,048
R01 · FY2005 · AI
Immune Induction to Genital Herpes Simplex Virus 2$37,476
R01 · FY2005 · AI
Immune Induction to Genital Herpes Simplex Virus 2$282,048
R01 · FY2004 · AI
RECTAL AND VAGINAL DENDRITIC CELLS$64,424
P51 · FY2004 · RR
RECTAL AND VAGINAL DENDRITIC CELLS IN SIV INFECTION$101,403
P51 · FY2003 · RR